These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26269678)

  • 41. Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study.
    Zaanan A; Williet N; Hebbar M; Dabakuyo TS; Fartoux L; Mansourbakht T; Dubreuil O; Rosmorduc O; Cattan S; Bonnetain F; Boige V; Taïeb J
    J Hepatol; 2013 Jan; 58(1):81-8. PubMed ID: 22989572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W; Li Y; He X; Chen Y
    Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.
    Bonekamp S; Bonekamp D; Geschwind JF; Corona-Villalobos CP; Reyes DK; Pawlik TM; Kamel IR
    J Magn Reson Imaging; 2014 Nov; 40(5):1103-11. PubMed ID: 24214827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival.
    Kim B; Won JH; Kim J; Kwon Y; Cho HJ; Huh J; Kim JK
    AJR Am J Roentgenol; 2021 Jun; 216(6):1566-1573. PubMed ID: 33852336
    [No Abstract]   [Full Text] [Related]  

  • 45. The prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinoma.
    Pang Q; Zhang JY; Xu XS; Song SD; Chen W; Zhou YY; Miao RC; Qu K; Liu SS; Dong YF; Liu C
    Scand J Clin Lab Invest; 2015 Jan; 75(1):73-84. PubMed ID: 25465804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.
    Sun AX; Cheng ZL; Wu PP; Sheng YH; Qu XJ; Lu W; Zhao CG; Qian GJ
    World J Gastroenterol; 2015 Mar; 21(10):2997-3004. PubMed ID: 25780298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.
    Chen YL; Ko CJ; Chien SY; Chen LS; Chen ML; Chi CW; Lai HW
    J Gastroenterol Hepatol; 2011 May; 26(5):851-7. PubMed ID: 21129015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M;
    Ann Surg; 2014 Feb; 259(2):336-45. PubMed ID: 23673768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma.
    Cho JY; Paik YH; Lim HY; Kim YG; Lim HK; Min YW; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Liver Int; 2013 Jul; 33(6):950-7. PubMed ID: 23601249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.
    Nakazawa T; Adachi S; Kitano M; Isobe Y; Kokubu S; Hidaka H; Ono K; Okuwaki Y; Watanabe M; Shibuya A; Saigenji K
    Oncology; 2007; 73(1-2):90-7. PubMed ID: 18337620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.
    Saeki I; Yamasaki T; Tanabe N; Iwamoto T; Matsumoto T; Urata Y; Hidaka I; Ishikawa T; Takami T; Yamamoto N; Uchida K; Terai S; Sakaida I
    PLoS One; 2015; 10(5):e0126649. PubMed ID: 25992784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy.
    Estfan B; Byrne M; Kim R
    Am J Clin Oncol; 2013 Aug; 36(4):319-24. PubMed ID: 22547010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
    Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
    Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
    Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
    Mondazzi L; Bottelli R; Brambilla G; Rampoldi A; Rezakovic I; Zavaglia C; Alberti A; Idèo G
    Hepatology; 1994 May; 19(5):1115-23. PubMed ID: 7513677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgery and prognostic factors of patients with epidural spinal cord compression caused by hepatocellular carcinoma metastases: retrospective study of 36 patients in a single center.
    Zhang D; Xu W; Liu T; Yin H; Yang X; Wu Z; Xiao J
    Spine (Phila Pa 1976); 2013 Aug; 38(17):E1090-5. PubMed ID: 23632333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.